Integenx Inc.
USPTO PatentsView assignee record - 36 granted patents across 20 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01L (Chemical OR Physical Laboratory Apparatus FOR General USE).
The verdict
According to USPTO PatentsView, Integenx ranks #8,836 of 49,997 tracked US assignees by granted-patent volume, with 36 patents across 20 technology areas.
- #8,836
- of 49,997 US assignees by volume
- Top 26%
- by Innovation Score (44.2/100)
- 16.1
- avg claims per patent
- +69%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R8836 · US Corporation #8,836 · 36 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 36 grants
- UPPER-Q #8,836/49,997
- PHOTO-FINISH Indian Institute OF…
- CPC-FOCUS B01L · 20 areas
- INNOV-PAR 44.2/100
- CLAIMS-RICH 16.1 claims/avg
- TYPE-USCORP US Corporation
- VEL-SURGE +69% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Indian Institute OF Technology Delhi (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Integenx’s 44.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Integenx
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Cetres Holdings · near
Cetres Holdings · near
44 score
- Hy-ko Products · near
Hy-ko Products · near
44 score
- Integenx · this assignee
Integenx · this assignee
44 score
- Sutro Biopharma · near
Sutro Biopharma · near
44 score
- Johannes Gutenberg-U… · near
Johannes Gutenberg-U… · near
44 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Integenx's Innovation Score is 44.2/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Integenx?
Each dot is one of Integenx’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Integenx’s own 16.1 claims/patent is ABOVE the 15.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Integenx's grants concentrate
Integenx Inc. is a focused PatentsView assignee: 20 CPC subclasses with 58.3% of grants classified under B01L (Chemical OR Physical Laboratory Apparatus FOR General USE). Peak complete grant year is 2024 (7 grants) versus a trough of 1 in 2018. By volume, Integenx sits between Indian Institute OF Technology Delhi and Isara Corporation.
Integenx's three-year grant acceleration
Integenx Inc. shows 13 grants in 2022–2024 against only 14 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Integenx's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Indian Institute…
Indian Institute OF Technology Delhi
36 patents
- Innodisk
Innodisk Corporation
36 patents
- Inria—Institut Na…
INRIA—INSTITUT National DE Recherche EN Informatique ET EN Automatique
36 patents
- Insilico Medicine…
Insilico Medicine IP Limited
36 patents
- Interaxon
Interaxon Inc.
36 patents
- INV Nylon Chemica…
INV Nylon Chemicals Americas, LLC
36 patents
- Ipsen Biopharm
Ipsen Biopharm Limited
36 patents
- Isara
Isara Corporation
36 patents
- Integenx ◀
Integenx Inc.
36 patents
What this shows Integenx holds 36 patents at rank #8,832, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Integenx
By rank, the assignees closest to #8,832 in granted patent volume.
- Indian Institute OF Technology Delhi #8,828 · 36 patents
- Innodisk Corporation #8,829 · 36 patents
- INRIA—INSTITUT National DE Recherche EN Informatique ET EN Automatique #8,830 · 36 patents
- Insilico Medicine IP Limited #8,831 · 36 patents
- Interaxon Inc. #8,833 · 36 patents
- INV Nylon Chemicals Americas, LLC #8,834 · 36 patents
- Ipsen Biopharm Limited #8,835 · 36 patents
- Isara Corporation #8,836 · 36 patents
Leaders in B01L (Chemical OR Physical Laboratory Apparatus FOR General USE)
Other assignees with the most granted patents in Integenx's primary technology class.
- The Regents of the University of California 239 in class
- Illumina, Inc. 232 in class
- Becton, Dickinson and Company 193 in class
- Bio-Rad Laboratories, Inc. 174 in class
- President and Fellows of Harvard College 165 in class
- Life Technologies Corporation 158 in class
- Roche Diagnostics Operations, Inc. 141 in class
- Siemens Healthcare Diagnostics Inc. 119 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Integenx, neither rank-band nor same-CPC leaders (those blocks stay above). In B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), Integenx ranks #89 of 1,325 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (44 here).
Integenx's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
44 Top 26% higher than 74% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 5.6% |
| 2016 | 2 | 5.6% |
| 2017 | 3 | 8.3% |
| 2018 | 1 | 2.8% |
| 2019 | 5 | 13.9% |
| 2020 | 6 | 16.7% |
| 2021 | 3 | 8.3% |
| 2022 | 2 | 5.6% |
| 2023 | 4 | 11.1% |
| 2024 | 7 | 19.4% |
| 2025partial year | 1 | 2.8% |
Which technologies does Integenx Inc. patent most?
Top 15 of 20 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Integenx Inc.'s patent record in context - here's where to go next.
- Integenx Inc.'s lead technology class is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), 58.3% of its portfolio - see every assignee active in that class. Explore B01L
- Ranked #8,836 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Integenx Inc. against Indian Institute OF Technology Delhi, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 44.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.